NPPB and heart failure: European Society of Cardiology (ESC) recommends use of brain natriuretic peptide (BNP) as a serum-based biomarker to identify patients with Stage A heart failure (which includes all anthracycline recipients) who could benefit from further cardiac investigation such as echocardiography [100].